Skip to main content
. Author manuscript; available in PMC: 2012 Jul 11.
Published in final edited form as: Am J Clin Oncol. 2009 Oct;32(5):453–459. doi: 10.1097/COC.0b013e3181925176

TABLE 2.

Selected Adverse Events (Grade 2-4) on S0312

Adverse Event Grade 2 (Moderate)# Grade 3 (Severe) Grade 4 (Life threatening)
Number of patients (%) Number of patients (%) Number of patients (%)
Blood/Bone Marrow
Hemoglobin 12 3 0
Leukocytes 10 4 1
Lymphopenia 8 0 1
Neutrophils 8 12 1
Platelets 4 0 1
Hemolysis 0 0 1
Cardiovascular
Cardiac Ischemia/infarction 0 1 0
Thrombosis/embolism(vascular accident) 1 0 0
Thrombosis/embolism 1 1 0
Phlebitis 2 0 0
Constitutional Symptoms
Fatigue 16 5 1
Weight Loss 2 0 0
Sweating 2 0 0
Fever 3 0 0
Insomnia 2 0 0
Dermatology/Skin
Rash: hand-foot skin reaction 5 2 0
Gastrointestinal
Diarrhea 4 1 0
Anorexia 8 0 0
Nausea 4 2 0
Vomiting 4 2 0
Mucositis (Oral) 1 1 0
Dehydration 2 0 0
Heartburn 1 1 0
Metabolic/Laboratory
AST 2 0 0
Hyperglycemia 1 1 0
Hypoalbuminemia 5 0 0
Hypokalemia 0 2 0
Neurology/Musculoskeletal
Neuro Pain: head/headache 1 1 0
Musculoskeletal-other 0 1 0
Pulmonary
Cough 2 0 0
Lung Pain: chest/thorax 2 0 0
Dyspnea 0 1 0
Renal
Renal failure 0 0 1
Maximum grade of any adverse event
Number 9 26 4
#

Grade 2 toxicities with only one reported adverse event and no grade 3 or 4 events were excluded.